Skip to main content
. 2016 Jan 5;16:4. doi: 10.1186/s12885-015-2019-x

Table 6.

Correlates of adherence to recommendations (N = 236)

Adherence to an increasing number of lifestyle recommendations
Model 1 Model 2 Model 3 Model 4
Variable B (95 % CI) p B (95 % CI) p B (95 % CI) p B (95 % CI) p
Age .000 (-.02; .02) .962 .004 (-.13; .02) .610 -.006 (-.02; .01) .441 -.010 (-.02; .01) .201
Female gender .655 (.18; 1.13) .007 .686 (.18; 1.19) .008 .398 (-.60; .86) .088 .462 (.02; .90) .039*
Marital status: with partner .566 (.08;1.06) .024 .460 (-.55; .98) .080 .284 (-.17; .74) .221 .391 (-.44; .83) .078
Education, low = ref
 Medium .200 (-.19; .59) .307 .215 (-.19; .62) .291 .035 (-.33; .40) .850 -.019 (-.37; .33) .915
 High .601 (.24; .96) .001 .534 (.15; .92) .006 .029 (-.34; .40) .877 .117 (-.33; .47) .517
Income, above average = ref.
 Average .067 (-.28; .42) .703 -.021 (-.38; .33) .907 -.063 (-.38; .25) .695 -.030 (-.33; .27) .844
 Below average .062 (-.40; .52) .789 .037 (-.48; .56) .889 -.203 (-.66; .26) .384 -.083 (-.52; .36) .709
Cancer type, other = ref
 Breast .459 (-.12; 1.04) .122 .281 (-.35; .91) .381 .130 (-.43; .69) .646 .046 (-.47; .60) .813
 Colon .291 (-.26; .84) .296 .224 (-.37; 82) .461 .087 (-.41;.62) .744 .145 (-.36; .65) .570
Treatment; all1 = ref
 Surgery alone .076 (-.47; .60) .805 -.004 (-.57; .56) .988 .128 (-.39; .64) .626 .033 (-.46; .52) .894
 Surgery + chemo .049 (-.31; .50) .644 .053 (-.37; .47) .803 .025 (-.35; .40) .897 .027 (-.33; .39) .882
 Surgery + radiation -.467 (-.90; -.04) .034 -.459 (-.91; -.01) .046 -.209 (-.69; .11) .157 -.264 (-.66; .14) .195
 Other .577 (-.11; 1.26) .100 .573 (-.48; 1.44) .123 .123 (-.53; 78) .711 .107 (-.52; .73) .736
Participating in aftercare -.083 (-.41; .24) .611 .006 (-.33; .35) .971 -.123 (-.42; .18) .420 -.105 (-.39; .18) .472
Time after treatment .009 (-.00; .02) .098 .010 (-.01; .02) .109 .009 (-.00; .02) .091 .012 (.00; .02) .024*
BMI .021 (-.01; .06) .230 .017 (-.02; .05) .347 .013 (-.02; .05) .445 .006 (-.03; .04) .734
Glob. Health/QoL - –.012 (–.03; .01) .080 –.010 (–.02; .00) .086 –.009 (–.02; .00) .115
Physical funct. –.003 (–.02; .02) .740 –.004 (–.02; .01) .604 –.004 (–.02; .01) .619
Role funct. .014 (.03; .03) .015 .010 (.01;.02) .036 .010 (.00; .02) .027*
Emotional funct. .001 (–.01; .01) .854 .006 (–.01; .02) .320 .007 (–.00; .02) .184
Cognitive funct. –.012 (–.02; –.00) .008 –.009 (–.02; –.00) .030 –.009 (–.02; –.00) .026*
Social funct. –.004 (–.01; .01) .493 –.004 (–.01; .01) .364 –.004 (–.01; .01) .400
Body Image .002 (–.01; .01) .658 .002 (–.01; .01) .657 .002 (–.01; .01) .554
Fatigue .001 (–.01; .01) .922 .000 (–.01; .01) .980 .001 (–.01; .01) .779
Nausea en Vomiting –.010 (–.03; .01) .254 –.010 (–.03; .01) .198 –.005 (–.02; .01) .517
Pain .002 (–.01; .01) .713 .005 (–.00; .01) .243 .006 (–.00; .01) .140
Dyspnea –.006 (–.01; .00) .124 .002 (–.01; .01) .620 .001 (–.01; .01) .799
Insomnia –.002 (–.01; .00) .576 .001 (–.01; .01) .998 .001 (–.01; .01) .992
Appetite loss –.002 (–.01; .01) .759 –.001 (–.01; .01) .856 –.001 (–.01; .01) .869
Constipation –.006 (–.01; .00) .202 –.002 (–.01; .01) .653 –.002 (–.01; .00) .544
Diarrhea –.001 (–.01; .01) .811 .001 (–.01; .01) .862 –.001 (–.01; .01) .824
Financial difficulties –.005 (–.01; .00) .268 –.003 (–.01; .01) .983 –.002 (–.01; .01) .531
Anxiety –.033 (–.10; .03) .325 –.007 (–.07; .05) .818 –.018 (–.07; .04) .531
Depression –.016 (–.09; .05) .652 –.049 (–.11; .01) .127 –.024 (–.09; .04) .445
Positive adjustment .023 (.00; .05) .048 .025 (.01; .05) .016 .020 (.00; .04) .045*
Negative adjustment .007 (–.02; .05) .648 .026 (–01; .05) .058 .023 (–.00; .05) .095
Illness perception .005 (–.01; .02) .573 .003 (–.01; .02) .693 .002 (–.01; .02) .825
PPO .042 (–.16; .24) .684 –.003 (–.19; .018) .975 .006 (–.17; .18) .944
NPO .088 (–.12; .29) .394 .115 (–.07; .30) .216 .089 (–.09; .26) .317
Alcohol: Attitude .084 (–.03; .20) .158 .020 (–.13; .17) .783
 Social support .000 (.00; .00) .184 .000 (.00; .001) .266
 Self–efficacy .052 (–.06; .16) .344 .053 (–.05; .16) .306
Nutrition: Attitude .373 (.17; .58) .000 .265 (.06; .47) .010*
 Social support –.001 (–.00; .00) .301 –.001 (–.00; .00) .295
 Self–efficacy .112 (–.06; .28) .200 –.037 (–.21; .14) .671
Physical Activity: Attitude –.184 (–.46; .09) .193 –.157 (–.44; .12) .269
 Social support –.001 (–.00; .00) .170 –.001 (–.00; .00) .206
 Self–efficacy .104 (–.07; .27) .227 .080 (–.09; .25) .347
Smoking: Attitude .153 (–.07; .38) .184 .100 (–.13; .34) .387
 Social support .020 (–.06; .10) .623 .000 (–.08; .08) .993
 Self–efficacy .323 (.17; .47) .000 .330 (.19; 48) .000**
Intention
 Alcohol cons. .066 (–.05; .18) .373
 Vegetable cons. .112 (–.04; .26) .144
 Fruit cons. .263 (.13; .39) .000**
 Physical activity .045 (–.16; .25) .668
 Smoking –.009 (–.12; .10) .874
Constant B (SE) .932 (.77) .795 (1.85) −2.728 (1.78) −3.72 (1.72)
R2 .172 .289 .502 .567
Sig. F Change .000 .109 .000 .000

Note: From Sequential Multiple Regression (continuous outcomes) and Sequential Logistic Regression (smoking) entry step 4 is displayed. Forced entry (enter) method was used. Abbreviations: ExpB: odds ratio; ref: reference group; BMI: Body Mass Index; EORTC: European Organisation for Research and Treatment of Cancer; QoL: Quality of Life; HADS: Hospital Anxiety and Depression Scale; MAC: Mental Adjustment to Cancer Scale; IPQ: Illness Perception Questionnaire; SPSIR–R:S Short Social Problem Solving Inventory–Revised; Chemo: chemotherapy; PPO: positive problem orientation; NPO: negative problem orientation; R2:correlation coefficient squared

1all = surgery + chemotherapy + radiation

2Dependent variable encoding: if participant is former smoker 1; if participant is current smoker 0 p–value of Wald test is presented

*p < 0.05; **p < 0.01